» Articles » PMID: 19196139

Influence of Adult Mesenchymal Stem Cells on in Vitro Vascular Formation

Overview
Date 2009 Feb 7
PMID 19196139
Citations 70
Authors
Affiliations
Soon will be listed here.
Abstract

The effective delivery of bioactive molecules to wound sites hasten repair. Cellular therapies provide a means for the targeted delivery of a complex, multiple arrays of bioactive factors to wound sites. Thus, the identification of ideal therapeutic populations is an essential aspect of this approach. In vitro assays can provide an important first step toward this goal by selecting populations that are likely suitable for more expensive and time-consuming in vivo assays. In this study, bone marrow-derived mesenchymal stem cells (BM-MSCs) were integrated into a three-dimensional coculture system that supports the development and stabilization of vascular tube-like structures. The presence of a limited number of BM-MSCs resulted in their coalignment with vascular structures, and it further resulted in increased tubule numbers and complexity. Thus, these studies suggest that BM-MSCs functionally interacted with and were attracted to in vitro formed vascular structures. Further, these cells also provided sufficient bioactive factors and matrix molecules to support the formation of tubular arrays and the stabilization of these arrays. This in vitro system provides a means for assessing the function of BM-MSCs in aspects of the angiogenic component of wound repair.

Citing Articles

Insights into the role of mesenchymal stem cells in cutaneous medical aesthetics: from basics to clinics.

Li J, Liu Y, Zhang R, Yang Q, Xiong W, He Y Stem Cell Res Ther. 2024; 15(1):169.

PMID: 38886773 PMC: 11184751. DOI: 10.1186/s13287-024-03774-5.


Role of Stem Cell-Derived Exosomes and microRNAs in Spinal Cord Injury.

Hwang J, Jang S, Kim C, Lee S, Jeong H Int J Mol Sci. 2023; 24(18).

PMID: 37762150 PMC: 10530823. DOI: 10.3390/ijms241813849.


Cell transplantation therapies for spinal cord injury focusing on bone marrow mesenchymal stem cells: Advances and challenges.

Huang L, Sun X, Pan H, Wang L, He C, Wei Q World J Stem Cells. 2023; 15(5):385-399.

PMID: 37342219 PMC: 10277963. DOI: 10.4252/wjsc.v15.i5.385.


Stem Cell Therapy in Spinal Cord Injury-Induced Neurogenic Lower Urinary Tract Dysfunction.

Ou Y, Huang C, Kao Y, Ho P, Tsai K Stem Cell Rev Rep. 2023; 19(6):1691-1708.

PMID: 37115409 DOI: 10.1007/s12015-023-10547-9.


Engineering Cell Microenvironment Using Nanopattern-Derived Multicellular Spheroids and Photo-Crosslinked Gelatin/Hyaluronan Hydrogels.

Zhang Z, Liu Y, Tao X, Du P, Enkhbat M, Lim K Polymers (Basel). 2023; 15(8).

PMID: 37112072 PMC: 10144125. DOI: 10.3390/polym15081925.


References
1.
Tille J, Pepper M . Mesenchymal cells potentiate vascular endothelial growth factor-induced angiogenesis in vitro. Exp Cell Res. 2002; 280(2):179-91. DOI: 10.1006/excr.2002.5635. View

2.
MacNeil S . Progress and opportunities for tissue-engineered skin. Nature. 2007; 445(7130):874-80. DOI: 10.1038/nature05664. View

3.
Tonnesen M, Feng X, Clark R . Angiogenesis in wound healing. J Investig Dermatol Symp Proc. 2001; 5(1):40-6. DOI: 10.1046/j.1087-0024.2000.00014.x. View

4.
Xueyong L, Shaozong C, Wangzhou L, Yuejun L, Xiaoxing L, Jing L . Differentiation of the pericyte in wound healing: The precursor, the process, and the role of the vascular endothelial cell. Wound Repair Regen. 2008; 16(3):346-55. DOI: 10.1111/j.1524-475X.2008.00374.x. View

5.
Klagsbrun M . The affinity of fibroblast growth factors (FGFs) for heparin; FGF-heparan sulfate interactions in cells and extracellular matrix. Curr Opin Cell Biol. 1990; 2(5):857-63. DOI: 10.1016/0955-0674(90)90084-r. View